A quantitative homogeneous assay for fragile X mental retardation 1 protein

Journal of Neurodevelopmental Disorders

Volumn 5, Issue 1, 2013, Pages 1-9

  Schutzius, Gabi ^a   Bleckmann, Dorothee ^a   Kapps Fouthier, Sandra ^a   di Giorgio, Francesco ^a   Gerhartz, Bernd ^a   Weiss, Andreas ^a,b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b IRBM   (Italy)

Author keywords

FMRP; Fragile X syndrome; Immunoassay; Time resolved F rster's resonance energy transfer

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN;

AMINO ACID SEQUENCE; ANTIBODY LABELING; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; ENERGY TRANSFER; EPITOPE MAPPING; ESCHERICHIA COLI; FIBROBLAST; FRAGILE X SYNDROME; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNODETECTION; LIMIT OF DETECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REPRODUCIBILITY; TIME RESOLVED FORSTER RESONANCE ENERGY TRANSFER;

EID: 84878805047     PISSN: 18661947     EISSN: 18661955     Source Type: Journal    
DOI: 10.1186/1866-1955-5-8     Document Type: Article

References (17)

1. Crawford DC, Acuna JM, Sherman SL: FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med 2001, 3:359-371.
2. Hagerman RJ, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A, Kronk R, Delahunty C, Hessl D, Visootsak J, Picker J, Gane L, Tranfaglia M: Advances in the treatment of fragile X syndrome. Pediatrics 2009, 123:378-390.
3. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL: Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991, 66:817-822.
4. Grønskov K, Brøndum-Nielsen K, Dedic A, Hjalgrim H: A nonsense mutation in FMR1 causing fragile X syndrome. Eur J Hum Genet 2011, 19:489-491.
5. Bradford C, Ikeda M, Budimirovic DB, Hjelm LN, Kaufmann WE, Warren ST: Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis. Am J Med Genet A 2008, 146A:1358-1367.
6. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL: The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 1993, 4:335-340.
7. Zalfa F, Giorgi M, Primerano B, Moro A, Di Penta A, Reis S, Oostra B, Bagni C: The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 2003, 112:317-327.
8. Bear MF, Huber KM, Warren ST: The mGluR theory of fragile X mental retardation. Trends Neurosci 2004, 27:370-377.
9. Dolen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, Bear MF: Correction of fragile X syndrome in mice. Neuron 2007, 56:955-962.
10. Jacquemont S, Curie A, Des Portes V, Torrioli MG, Berry-Kravis E, Hagerman RJ, Ramos FJ, Cornish K, He Y, Paulding C, Neri G, Chen F, Hadjikhani N, Martinet D, Meyer J, Beckmann JS, Delange K, Brun A, Bussy G, Gasparini F, Hilse T, Floesser A, Branson J, Bilbe G, Johns D, Gomez-Mancilla B: Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci Transl Med 2011, 3:64ra1.
11. Iwahashi C, Tassone F, Hagerman RJ, Yasui D, Parrott G, Nguyen D, Mayeur G, Hagerman PJ: A quantitative ELISA assay for the fragile x mental retardation 1 protein. J Mol Diagn 2009, 11:281-289.
12. Willemsen R, Anar B, De Diego Otero Y, de Vries BB, Hilhorst-Hofstee Y, Smits A, van Looveren E, Willems PJ, Galjaard H, Oostra BA: Noninvasive test for fragile X syndrome, using hair root analysis. Am J Hum Genet 1999, 65:98-103.
13. Bidinosti M, Shimshek DR, Mollenhauer B, Marcellin D, Schweizer T, Lotz GP, Schlossmacher MG, Weiss A: Novel one-step immunoassays to quantify alpha-synuclein: applications for biomarker development and high-throughput screening. J Biol Chem 2012, 287:33691-705
14. Armbruster DA, Pry T: Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 2008, 29(Suppl 1):49-52.
15. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999, 4:67-73.
16. Biacsi R, Kumari D, Usdin K: SIRT1 inhibition alleviates gene silencing in Fragile X mental retardation syndrome. PLoS Genet 2008,4:e1000017
17. Coffee B, Zhang F, Warren ST, Reines D: Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet 1999, 22:98-101